Celprogen Introduces an in vivo Model for Human Brain Cancer (Human

[News]

Celprogen Inc., a Global leader in the Stem Cell Research and Therapeutics industry for development of stem cell technologies in regenerative medicine, today announced that they have successfully validated an in vivo model system for testing efficacy of cancer drugs and also novel drug candidates for Human Glioblastoma.

More... (http://www.news-medical.net/?id=43061)